ATE27701T1 - 2-carbamimidoyl-6-substituierte-1-carbadethiape - 2-em-3-carbonsaeure, verfahren zur herstellung und sie enthaltendes antibiotisches arzneipraeparat. - Google Patents

2-carbamimidoyl-6-substituierte-1-carbadethiape - 2-em-3-carbonsaeure, verfahren zur herstellung und sie enthaltendes antibiotisches arzneipraeparat.

Info

Publication number
ATE27701T1
ATE27701T1 AT81108420T AT81108420T ATE27701T1 AT E27701 T1 ATE27701 T1 AT E27701T1 AT 81108420 T AT81108420 T AT 81108420T AT 81108420 T AT81108420 T AT 81108420T AT E27701 T1 ATE27701 T1 AT E27701T1
Authority
AT
Austria
Prior art keywords
carbamimidoyl
aryl
substituted
alkyl
compounds
Prior art date
Application number
AT81108420T
Other languages
English (en)
Inventor
Burton G Christensen
David B R Johnston
Susan M Schmitt
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE27701T1 publication Critical patent/ATE27701T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT81108420T 1980-10-17 1981-10-16 2-carbamimidoyl-6-substituierte-1-carbadethiape - 2-em-3-carbonsaeure, verfahren zur herstellung und sie enthaltendes antibiotisches arzneipraeparat. ATE27701T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19785680A 1980-10-17 1980-10-17
EP81108420A EP0050334B1 (de) 1980-10-17 1981-10-16 2-Carbamimidoyl-6-substituierte-1-carbadethiapen-2-em-3-carbonsäure, Verfahren zur Herstellung und sie enthaltendes antibiotisches Arzneipräparat

Publications (1)

Publication Number Publication Date
ATE27701T1 true ATE27701T1 (de) 1987-06-15

Family

ID=22731012

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81108420T ATE27701T1 (de) 1980-10-17 1981-10-16 2-carbamimidoyl-6-substituierte-1-carbadethiape - 2-em-3-carbonsaeure, verfahren zur herstellung und sie enthaltendes antibiotisches arzneipraeparat.

Country Status (9)

Country Link
EP (1) EP0050334B1 (de)
JP (1) JPS5795989A (de)
AT (1) ATE27701T1 (de)
DE (1) DE3176244D1 (de)
DK (1) DK458781A (de)
ES (1) ES8301990A1 (de)
GR (1) GR77296B (de)
IE (1) IE53047B1 (de)
PT (1) PT73791B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES514240A0 (es) * 1981-08-03 1984-04-16 Merck & Co Inc Un procedimiento para la prepracion de nuevos derivados de acidos 2-carbamimidoil-1-,carbadestiapen-2-en-3-carboxilados.
US4710568A (en) * 1982-04-09 1987-12-01 Bristol-Myers Company Carbapenem antibiotics
US4642341A (en) * 1982-04-09 1987-02-10 Bristol-Myers Company Carbapenem antibiotics
US4640799A (en) * 1982-06-18 1987-02-03 Bristol-Myers Company Carbapenem antibiotics
US4665170A (en) * 1982-06-18 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
FI832619A (fi) * 1982-07-26 1984-01-27 Sandoz Ag Fluoralkylerade karbapenemderivat
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
NZ205626A (en) * 1982-09-28 1986-12-05 Bristol Myers Co Carbapenem antibiotics
US4732977A (en) * 1982-09-28 1988-03-22 Bristol Myers Company Carbapenem antibiotics
ZA836966B (en) * 1982-09-28 1984-04-25 Bristol Myers Co Carbapenem antibiotics
CH660736A5 (de) * 1983-10-03 1987-06-15 Sanraku Inc Carbapenemderivate.
US4717728A (en) * 1983-11-21 1988-01-05 Merck & Co., Inc. Cyclic amidinyl and cyclic guanidinyl thio carbapenems
US4713451A (en) * 1984-04-09 1987-12-15 Merck & Co., Inc. Crystalline dimethyliminothienamycin
AU583113B2 (en) * 1985-04-27 1989-04-20 Sankyo Company Limited Carbapenem derivatives
DE68916908T2 (de) * 1988-11-08 1994-12-01 Daiichi Seiyaku Co Carbapenemderivate.
US5496816A (en) * 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US5498777A (en) * 1994-07-20 1996-03-12 Merck & Co., Inc. 3-thioheteroaryl cephalosporin compounds, compositions and methods of use
KR970706284A (ko) 1994-09-16 1997-11-03 나가사까 겐지로 신규의 카르바페넴 유도체(novel carbapenem deriative)
WO1996008491A1 (fr) * 1994-09-16 1996-03-21 Banyu Pharmaceutical Co., Ltd. Nouveau derive de carbapeneme

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK170778A (da) * 1977-05-05 1979-01-15 Merck & Co Inc Fremgangsmaade til fremstilling af n-alkyl-n-iminomethyl-derivater af thienamycin
AU4061378A (en) * 1977-10-19 1980-04-17 Merck & Co., Inc. 1-azabicyclo (3.2.0) hept-2-enes
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
US4189493A (en) * 1977-12-28 1980-02-19 Merck & Co., Inc. N-heterocyclic derivatives of thienamycin
DE2961882D1 (en) * 1978-08-25 1982-03-04 Beecham Group Plc Beta-lactam anti-bacterials, compositions containing them and a process for their preparation
JPS5622787A (en) * 1979-07-27 1981-03-03 Sanraku Inc Beta-lactam compound
EP0017992A1 (de) * 1979-04-19 1980-10-29 Merck & Co. Inc. 2-Substituierte-6-substituierte-1-Carbadethiapen-2-em-3-carbonsäuren, Verfahren zu ihrer Herstellung, sie enthaltende antibiotische pharmazeutische Zusammensetzungen und Verfahren zur Herstellung von Zwischenprodukten
JPS5649383A (en) * 1979-09-29 1981-05-02 Sanraku Inc Beta-lactam compound
IE52147B1 (en) * 1980-03-27 1987-07-08 Merck & Co Inc 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation
JPS56154484A (en) * 1980-05-01 1981-11-30 Merck & Co Inc 1-carbapenems derived from-4azetidinone and manufacture of intermediate therefor
IN155384B (de) * 1980-05-14 1985-01-19 Pfizer
JPH0471913A (ja) * 1990-07-10 1992-03-06 Nissan Motor Co Ltd 車両用サスペンション

Also Published As

Publication number Publication date
PT73791A (en) 1981-11-01
ES506284A0 (es) 1983-01-01
DK458781A (da) 1982-04-18
EP0050334A1 (de) 1982-04-28
IE812408L (en) 1982-04-17
GR77296B (de) 1984-09-11
JPS5795989A (en) 1982-06-15
ES8301990A1 (es) 1983-01-01
EP0050334B1 (de) 1987-06-10
IE53047B1 (en) 1988-05-25
DE3176244D1 (en) 1987-07-16
PT73791B (en) 1983-10-14

Similar Documents

Publication Publication Date Title
ATE27701T1 (de) 2-carbamimidoyl-6-substituierte-1-carbadethiape - 2-em-3-carbonsaeure, verfahren zur herstellung und sie enthaltendes antibiotisches arzneipraeparat.
ATE46696T1 (de) 1- und 1,1-disubstituierte, 6-substituierte, 2carbamimidoyl-1-carbadethiapen-2-em-3carbons|uren, verfahren zur herstellung und diese enthaltende antibiotische zusammensetzung.
JPS5569586A (en) 11* 66 and 22substitutedd11carbaa22penenn 33carboxylic acid
ZA918734B (en) Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes for preparing them.
ES474288A1 (es) Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo-(3,2,0)-hept-2-en-carboxilico 3 y 6-sus-tituidos
NO177535C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidforbindelser
DE69332860D1 (de) Bicyklische fibrinogen antagoniste
ATE14423T1 (de) Hydroxamsaeurederivate vom typ der mannich-basen mit verbesserter biologischer verfuegbarkeit von nicht-steroiden entzuendungshemmern, verfahren zur herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzung.
ATE141606T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung
ATE19773T1 (de) Nitroaliphatische verbindungen, verfahren zu deren herstellung und deren verwendung.
ES8207538A1 (es) Un procedimiento para la preparacion de acidos 1-carbadetiapen-2-em-3-carboxilicos 6-, 1- y 2-sustituidos.
ATE212637T1 (de) Anitbiotisch wirksame cephalosporine und verfahren zu ihrer herstellung
AU639154B2 (en) New imidazole compounds, a process for the preparation thereof, and pharmaceutical compositions containing them
DE69625795T2 (de) Thiazolidinedionderivate mit antidiabetischen, hypolipidämischen und antihypertensiven Eigenschaften, Verfahren zu deren Herstellung und pharmazeutischen Zusammenstellungen, die sie enthalten
EA199900589A1 (ru) Производные эритромицина, способ их получения и их применение в качестве лекарственных средств
ATE131480T1 (de) Pyrimidoindolderivate und verfahren zu ihrer herstellung
DE3862426D1 (de) 2-selenomethyl-1,4-dihydropyridine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
JPS5589257A (en) New easily-absorbable sulfur-containing prodrug of non- steroidal antiphlogistic, and their drug compositions
HUT57221A (en) Process for producing pyrrolo(2,1-b)thiazol derivatives and pahrmaceutical compositions contiaining them as active components

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time